HRT Financial’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-415,058
Closed -$5.45M – 4806
2026
Q1
$5.45M Buy
415,058
+261,319
+170% +$4.6M 0.01% 940
2025
Q4
$4.08M Buy
153,739
+72,612
+90% +$1.97M 0.01% 879
2025
Q3
$2.44M Buy
81,127
+7,228
+10% +$248K 0.01% 1039
2025
Q2
$3.1M Buy
+73,899
New +$2.67M 0.01% 736
2025
Q1
– Sell
-37,223
Closed -$1.29M – 2970
2024
Q4
$1.29M Buy
+37,223
New +$1.08M 0.01% 950
2024
Q3
– Sell
-99,979
Closed -$2.63M – 2792
2024
Q2
$2.63M Buy
99,979
+40,235
+67% +$964K 0.01% 629
2024
Q1
$1.3M Buy
+59,744
New +$1.27M 0.01% 762
2023
Q3
– Sell
-174,388
Closed -$2.31M – 2760
2023
Q2
$2.31M Buy
+174,388
New +$2.36M 0.02% 555
2023
Q1
– Sell
-28,172
Closed -$313K – 2835
2022
Q4
$313K Buy
+28,172
New +$283K ﹤0.01% 1695
2022
Q2
– Sell
-402,274
Closed -$5.28M – 3318
2022
Q1
$5.28M Buy
+402,274
New +$6.05M 0.04% 279

Other funds holding KD

HRT Financial's KD Position: Q2 2026 in Review

HRT Financial sold out of Kyndryl (KD) in Q2 2026, closing a stake of 415,058 shares — an estimated $5.45M sold.

HRT Financial first reported a position in KD in Q1 2022 and held it in 10 quarters. The position peaked at $5.45M in Q1 2026. 676 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • HRT Financial reported no remaining Kyndryl position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 415,058 Kyndryl shares in Q2 2026, an estimated $5.45M.
  • HRT Financial first reported a position in Kyndryl in Q1 2022 and held it in 10 quarters.
  • HRT Financial's Kyndryl position peaked at $5.45M in Q1 2026.
  • 676 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.